All lobbying filings

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade association

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2025

Official filing document

Bills named in this filing 3

HR 946
ORPHAN Cures Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to reimbursement under Medicare Part B Issues related to Medicare Part D, generally Issues related to the 340B Drug Pricing Program

Health Issues

Issues related to drug pricing and value, generally Issues related to pharmacy benefit managers and drug rebate reform Issues related to drug patents and patent reporting requirements H.R. 946, the ORPHAN Cures Act H.R. 1262/S. 932, the Give Kids a Chance Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.